The benefits of a year round event models are endless. Implementing a digital media platform with the right mix of technology, skilled personnel, consultants, vendors and “content” strategy prove extremely profitable. This approach enables the show organizer, attendees, exhibitors, sponsors, presenters and prospects to engage before, during and after a live event (including, education, operations, promotion, sales, content, data, social media, face-to-face).

1. Creating the 365 Day Long
Conference and Expo
March 10, 2014
3:15 PM– 4:30 PM
Hashtag: #ideas14 LE3
Barbara A. Myers, CAE, Vice President, Association
Services, IMN Solutions
Kevin Miller, President, Frost Miller Group

2. Learner Outcomes
• To learn benefits of a
year round event model.
• To develop a strategy for
transitioning an
event/exhibition to a year
round experience.
• To gain and share ideas
for specific tactics that
can be implemented.

3. What is a 365 Day Experience?
• IAEE Future Trends Task Force – White Paper: Future Trends
Impacting the Exhibition and Events Industry.
• Transitioning ―episodic‖ events to year-round communities
around specific content
• Implementing a digital media platform with the right mix of
technology, skilled personnel, consultants, vendors and
―content‖ strategy.
• Enables the show organizer, attendees, exhibitors, sponsors,
presenters and prospects to engage before, during and after a
live event (including, education, operations, promotion, sales,
content, data, social media, face-to-face)

4. Benefits
• Counters impact of digital media’s 24/7 competitive
interaction with fixed date F2F events
• Increases engagement (among all event
stakeholders which value/ROI)
• Expands reach and generates impressions outside
existing databases, lists, etc.
• Financial (revenue generation/cost containment)
• Addresses generation challenges and reaches
―online generation‖

5. ―The Next On-line Generation‖
How Tweens are
Communicating!

6. By the Numbers…

7. Strategy and Planning
Strategic Planning Goals
Audience
Assessment
Marketing
Execution
Engagement
Tactics

8. Strategy
• Identify events to transition from ―episodic‖ to year-round
communities aligned with strategic priorities and growth goals of
the association
• Evaluate current digital media strategy and use
• Answer question - ―What kind of value should I be creating for my
audience year-round that makes the event the natural next step in
their buying process?‖

9. Goals
• Engagement
• Mission Fulfillment
• Revenue

10. Audience Assessment
Non-
Attendees
Exhibitor/Sponsors Members
Speakers
Press/Bloggers

11. Marketing
• Clearly Defined Plan
• Describe Target Audience
• Tactics Align with Audience
• Maximize Registration Opportunities
• Use Social Media to Recruit, Engage, and
Retain Audiences
• Seek Ongoing, Persistent Relationships with
Audience

12. Content in Action
Page(1(of(3
From: Renee&Smith
To: Barbara&Myers
CC: Danielle&Hould
Here’s&the&combined&email.
Renee
&
From: ISPE [mailto:ask@ispe.org]
Sent: Wednesday, September 11, 2013 7:46 AM
To: Renee Smith
Subject: ** iMIS Email Marketing Test ** Don't Miss ISPE's Upcoming Events
Send to a friend | Mobile Version
While ISPE finalizes programming for upcoming educational events, be sure to visit our conference
websites for the latest updates on speakers, agendas and session details.
The State of QbD in the BioPharmaceutical Industry:
Criticality Assessment, Design Space Implementation and
Control
10 - 11 April 2013 • San Francisco, California USA
Can your company afford the cost of production without
QbD? Quality by Design can significantly alter the risk landscape
and produce significant business benefits.
This groundbreaking event offers you in-depth case studies,
lessons learned and best practices in implementing QbD.
Explore challenges and solutions with experts and peers in
workshops on design space, control strategies, successful
dossiers and lifecycle management.
Who is attending? Leaders from Abbott, Amgen, Eli Lilly,
Page(2(of(3
Genentech, MedImmune, Merck, Pfizer and more!
Early bird registration ends 12 March 2013.
Add this conference to your calendar
Redefining the "C" in CGMP: Ensuring a Reliable Supply of
Quality Medicines
11 - 13 June 2013 • Baltimore, Maryland USA
ISPE and FDA collaborate to provide content focused on
creating and maintaining a quality culture. Special events include
Breakfast with the Inspectors, Meet the Press and Hot Topic
Discussion Forum.
Delegates will also have the unique opportunity to be among the
first to hear results of ISPE’s Drug Shortage Survey, which will
be announced at the conference.
Early bird registration ends 13 May 2013.
Add this conference to your calendar
Biotechnology 2013: Looking Ahead to the 4th Decade
27 - 28 August 2013 • Durham, North Carolina USA
As the modern Biotechnology Industry moves into its fourth
decade, the dynamics of the industry are changing on many
different fronts. This 2-day educational intensive will provide
focused content on:
Biopharmaceutical manufacturing and process
development
Facility design and integration
Compliance and process validation
Early bird registration ends 30 July 2013.
Add this conference to your calendar
14% Open Rate
23% Open Rate Page(1(of(2
To: Renee Smith
Subject: ** iMIS Email Marketing Test ** Learn How the A-VAX Case Study Can Help You
If this email does not display properly, click here to view the mobile version.
What You Need to Know
about the A-VAX Case Study
Register today to learn practical applications
directly from study participants
Register Today >>
Understand and take away practical applications from the
A-VAX Case Study at Biotechnology, a 2-day Symposium
27 – 28 August 2013 in Durham, NC.
Sam Venugopal, Director, PricewaterhouseCoopers and
Bradley Kosiba, PhD, CPIP, Principal, BK Collaborative
LLC will lead this important workshop where delegates will
Biotechnology is
brought to you by
ISPE and the Biotech
CoP in cooperation
with your local CaSA
Chapter!
Explore the content and application of the A-VAX
Case Study.
Understand how QbD can be applied to vaccine
development and benefit the manufacturing
lifecycle.
Identify the specific challenges involved in QbD
and ways they can be overcome in the vaccine
environment.
Gain insight into the challenges regulators face as
they better define their expectations related to QbD.
Speakers from companies involved will participate
Michael Washabaugh, PhD, Senior Director,
MedImmune
Paul Rohlfing, Senior Director Global CMC, Pfizer, Inc.
Michael Schwartz, Associate Director Global Regulatory
Affairs, GlaxoSmithKline-Vaccines
Michael Kosinski, Senior Principle Scientist, Merck &
Co, Inc.
Take a quick, 3-question quiz about the A-VAXTake a quick, 3-question quiz about the A-VAX
Case Study for a chance to win aCase Study for a chance to win a complimentarycomplimentary
registration to this conferenceregistration to this conference.*.*
Learn more at: www.ISPE.org/2013BiotechConference
*Registration includes conference fee only valued at ($1745-2,014). Winner is
responsible for lodging and travel expenses. Contest only applicable to new
registrants. Winner will be announced and contacted on 12 August 2013
© 2013 ISPE
60% Open Rate

13. Execution
• Evaluate internal/external
resources
• Buy-in from organizational
stakeholders
• Roles and responsibilities
• Strategy/goals, goal oriented
tactical plan and time lines
• Budget
• Training
• Evaluate against goals

14. Engagement Tactics
Communication
• Digital content and media: streaming and downloads
• SEM advertising: banner and text
• Microsites and similar event-branded websites – content hub!
• Content sharing: Slideshare, iTunesU, YouTube
• Email: both email marketing and updates/advisory
• Twitter (or similar) as back channel during presentation
Participation
• Online/mobile gaming and sweepstakes
• Mobile-specific applications such as attendee networking/notification
• ―Virtual/Hybrid‖ events and content distribution (―remote‖ education, networking, etc.)
• Physical interactive touchscreens, interactive environments
• Augmented/reality,enhanced reality
• Tablet-guided discussion — animations, imagery, diagrams
• NFC, RFID — lead capture, measurement
• Gamification
• QR Codes — more info, check-in’s credential exchange
Propagation
• Blogs and similar one-to-many publishing platforms
• -Twitter, Facebook, association propriety social networks and other one-to-one engagement platforms
• #Hashtags
• RSS and other content syndication

15. Questions?

16. Contact Us
Barbara A. Myers, CAE
Vice President, Association Services
IMN Solutions
bmyers@imnsolutions.com
Kevin Miller
President
Frost Miller Group
kmiller@frostmiller.com